Menu Search
Equities

Botanix Pharmaceuticals Ltd

BOT:ASX

Botanix Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.32
  • Today's Change0.005 / 1.59%
  • Shares traded3.66m
  • 1 Year change+106.45%
  • Beta2.6579
Data delayed at least 20 minutes, as of Nov 22 2024 05:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Botanix Pharmaceuticals Ltd had net income fall 51.52% from a loss of 9.15m to a larger loss of 13.87m despite a 301.17% increase in revenues from 168.89k to 677.54k.
Gross margin--
Net profit margin-2,047.07%
Operating margin-2,053.94%
Return on assets-20.20%
Return on equity-21.07%
Return on investment-21.07%
More ▼

Cash flow in AUDView more

In 2024, Botanix Pharmaceuticals Ltd increased its cash reserves by 673.71%, or 69.06m. Cash Flow from Financing totalled 95.10m or 14,035.82% of revenues. In addition the company used 8.13m for operations while cash used for investing totalled 18.00m.
Cash flow per share-0.0092
Price/Cash flow per share--
Book value per share0.0601
Tangible book value per share0.0438
More ▼

Balance sheet in AUDView more

Botanix Pharmaceuticals Ltd has little financial risk as the capital structure does not rely on leverage.
Current ratio22.21
Quick ratio21.89
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.